Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 169 Changle Road, Xi'an, Shaanxi, 710032, China.
Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
Cell Mol Life Sci. 2024 Aug 22;81(1):365. doi: 10.1007/s00018-024-05411-z.
This study aims to uncover the heterogeneity of endothelial cells (ECs) in colorectal cancer (CRC) and their crucial role in angiogenesis, with a special focus on tip cells. Using single-cell RNA sequencing to profile ECs, our data suggests that CRC ECs predominantly exhibit enhanced angiogenesis and decreased antigen presentation, a shift in phenotype largely steered by tip cells. We also observed that an increase in the density and proportion of tip cells correlates with CRC occurrence, progression, and poorer patient prognosis. Furthermore, we identified endothelial cell-specific molecule 1 (ESM1), specifically expressed in tip cells, sustains a VEGFA-KDR-ESM1 positive feedback loop, promoting angiogenesis and CRC proliferation and migration. We also found the enrichment of KDR in tip cells and spotlight a unique long-tail effect in VEGFA expression: while VEGFA is primarily expressed by epithelial cells, the highest level of VEGFA expression is found in individual myeloid cells. Moreover, we observed that effective PD-1 blockade immunotherapy significantly reduced tip cells, disrupting the VEGFA-KDR-ESM1 positive feedback loop in the process. Our investigation into the heterogeneity of ECs in CRC at a single-cell level offers important insights that may contribute to the development of more effective immunotherapies targeting tip cells in CRC.
本研究旨在揭示结直肠癌(CRC)中内皮细胞(ECs)的异质性及其在血管生成中的关键作用,特别关注尖端细胞。我们通过单细胞 RNA 测序对 ECs 进行了分析,数据表明 CRC ECs 主要表现出增强的血管生成和降低的抗原呈递,这种表型的转变主要由尖端细胞驱动。我们还观察到,尖端细胞密度和比例的增加与 CRC 的发生、进展和患者预后不良相关。此外,我们发现内皮细胞特异性分子 1(ESM1)在尖端细胞中特异性表达,维持了一个 VEGFA-KDR-ESM1 的正反馈环,促进了血管生成以及 CRC 的增殖和迁移。我们还发现 KDR 在尖端细胞中的富集,并强调了 VEGFA 表达中的独特长尾效应:虽然 VEGFA 主要由上皮细胞表达,但 VEGFA 的最高表达水平存在于单个髓系细胞中。此外,我们观察到有效的 PD-1 阻断免疫疗法可显著减少尖端细胞,从而破坏 VEGFA-KDR-ESM1 正反馈环。我们对 CRC 中 ECs 的单细胞异质性的研究提供了重要的见解,可能有助于开发针对 CRC 中尖端细胞的更有效的免疫疗法。